Histological changes of an injectable rhBMP-2/calcium phosphate cement in vertebroplasty of rhesus monkey

Spine (Phila Pa 1976). 2009 Aug 15;34(18):1887-92. doi: 10.1097/BRS.0b013e3181b0e579.

Abstract

Study design: A histologic study of recombinant human bone morphogenetic protein-2/calcium phosphate cement (rhBMP-2/CPC) using adult rhesus monkeys in vivo.

Objective: To evaluate the histologic changes of rhBMP-2/CPC in vertebroplasty and determine the feasibility of this bone substitution instead of polymethylmethacrylate (PMMA).

Summary of background data: Previous studies have shown that the new rhBMP-2/nanoscale CPC has a suitable strength and injection for vertebroplasty. However, the osteoinductive properties and biodegradable characteristics are still unclear.

Methods: Percutaneous vertebroplasty (PVP) was performed in 4 adult rhesus monkeys of 2 groups. Ten vertebral bodies (VBs) from T10-L7 of each rhesus were selected, and the 20 VBs in each group were randomly divided into 3 subgroups. Subgroup A (rhBMP-2/CPC): 8 VBs, filled with rhBMP-2/CPC; Subgroup B (PMMA): 6 VBs, filled with injectable PMMA; Subgroup C (control): 6 VBs, filled with normal saline. The 2 rhesus monkeys from each of the groups were killed at 2 and 6 months after operation, respectively. Individual specimens from the 40 VBs were collected for histologic observation.

Results: In subgroup A, radiographic and histologic observations showed that the part of the rhBMP-2/CPC cement degraded with new bone and new vessel ingrowths, into the material, after 2 months. In addition, gaps, fibrous hyperplasia, or sclerotic callus were not found in the interface. After 6 months, the cement was nearly all replaced by mature bone tissue. In subgroup B, the inflammatory cell infiltration and fibrous membrane gapping were found after 2 months, and subsided partly at 6 months. But no new bone formation and material degradation were discovered. In subgroup C, the tunnels were filled with irregular new trabeculae after 2 months and unrecognizable from the surrounding mature bone after 6 months.

Conclusion: It is confirmed that the rhBMP-2/CPC is an osteoinductive and biodegradable material (in animal trials). It may also be an alternative to PMMA in order to achieve biostabilization in a vertebroplasty.

MeSH terms

  • Animals
  • Biocompatible Materials / administration & dosage
  • Biocompatible Materials / metabolism
  • Bone Cements
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins / administration & dosage*
  • Bone Morphogenetic Proteins / metabolism
  • Bone Regeneration / drug effects
  • Bone Substitutes / administration & dosage*
  • Bone Substitutes / metabolism
  • Calcium Phosphates / administration & dosage*
  • Calcium Phosphates / metabolism
  • Humans
  • Injections
  • Lumbar Vertebrae / injuries
  • Lumbar Vertebrae / metabolism
  • Lumbar Vertebrae / surgery
  • Macaca mulatta
  • Polymethyl Methacrylate / administration & dosage
  • Polymethyl Methacrylate / metabolism
  • Random Allocation
  • Recombinant Proteins / administration & dosage*
  • Recombinant Proteins / metabolism
  • Spinal Fractures / metabolism
  • Spinal Fractures / surgery
  • Thoracic Vertebrae / injuries
  • Thoracic Vertebrae / metabolism
  • Thoracic Vertebrae / surgery
  • Transforming Growth Factor beta / administration & dosage*
  • Transforming Growth Factor beta / metabolism
  • Vertebroplasty / methods*

Substances

  • Biocompatible Materials
  • Bone Cements
  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • Bone Substitutes
  • Calcium Phosphates
  • Recombinant Proteins
  • Transforming Growth Factor beta
  • recombinant human bone morphogenetic protein-2
  • Polymethyl Methacrylate
  • calcium phosphate